1、Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and
treatment options[J]. Med Clin North Am, 2020, 104(2): 293-311.
DOI: 10.1016/j.mcna.2019.10.007.Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and
treatment options[J]. Med Clin North Am, 2020, 104(2): 293-311.
DOI: 10.1016/j.mcna.2019.10.007.
2、Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis[J]. Nat
Rev Dis Primers, 2016, 2: 16072. DOI: 10.1038/nrdp.2016.72.Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis[J]. Nat
Rev Dis Primers, 2016, 2: 16072. DOI: 10.1038/nrdp.2016.72.
3、GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years lived
with disability for 354 diseases and injuries for 195 countries and
territories, 1990-2017: a systematic analysis for the Global Burden of
Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI:
10.1016/S0140-6736(18)32279-7.GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years lived
with disability for 354 diseases and injuries for 195 countries and
territories, 1990-2017: a systematic analysis for the Global Burden of
Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI:
10.1016/S0140-6736(18)32279-7.
4、Johnson VL, Hunter DJ. The epidemiology of osteoarthritis[J].
Best Pract Res Clin Rheumatol, 2014, 28(1): 5-15. DOI: 10.1016/
j.berh.2014.01.004.Johnson VL, Hunter DJ. The epidemiology of osteoarthritis[J].
Best Pract Res Clin Rheumatol, 2014, 28(1): 5-15. DOI: 10.1016/
j.berh.2014.01.004.
5、Weinreb RN, Aung T, Medeiros FA. The pathophysiology and
treatment of glaucoma: a review[J]. JAMA, 2014, 311(18): 1901-1911.
DOI: 10.1001/jama.2014.3192.Weinreb RN, Aung T, Medeiros FA. The pathophysiology and
treatment of glaucoma: a review[J]. JAMA, 2014, 311(18): 1901-1911.
DOI: 10.1001/jama.2014.3192.
6、Barkana Y, Dorairaj S. Re: Tham et Al.: global prevalence of glaucoma
and projections of glaucoma burden through 2040: a systematic
review and meta-analysis (Ophthalmology 2014;121: 2081-90)[J].
Ophthalmology, 2015, 122(7): e40-e41. DOI: 10.1016/j.ophtha.
2014.11.030.Barkana Y, Dorairaj S. Re: Tham et Al.: global prevalence of glaucoma
and projections of glaucoma burden through 2040: a systematic
review and meta-analysis (Ophthalmology 2014;121: 2081-90)[J].
Ophthalmology, 2015, 122(7): e40-e41. DOI: 10.1016/j.ophtha.
2014.11.030.
7、Quigley HA. Glaucoma[J]. Lancet, 2011, 377(9774): 1367-1377.
DOI: 10.1016/S0140-6736(10)61423-7.Quigley HA. Glaucoma[J]. Lancet, 2011, 377(9774): 1367-1377.
DOI: 10.1016/S0140-6736(10)61423-7.
8、Comparison of glaucomatous progression between untreated patients
with normal-tension glaucoma and patients with therapeutically
reduced intraocular pressures. Collaborative Normal-Tension
Glaucoma Study Group[J]. Am J Ophthalmol, 1998, 126(4): 487-497.DOI: 10.1016/s0002-9394(98)00223-2.Comparison of glaucomatous progression between untreated patients
with normal-tension glaucoma and patients with therapeutically
reduced intraocular pressures. Collaborative Normal-Tension
Glaucoma Study Group[J]. Am J Ophthalmol, 1998, 126(4): 487-497.DOI: 10.1016/s0002-9394(98)00223-2.
9、Kang J M, Tanna A P. Glaucoma[J]. Med Clin North Am, 2021,
105(3):493-510. DOI: 10.1016/j.mcna.2021.01.004.Kang J M, Tanna A P. Glaucoma[J]. Med Clin North Am, 2021,
105(3):493-510. DOI: 10.1016/j.mcna.2021.01.004.
10、Carreon T, van der Merwe E, Fellman RL, et al. Aqueous outflow - A
continuum from trabecular meshwork to episcleral veins[J]. Prog Retin
Eye Res, 2017, 57: 108-133. DOI: 10.1016/j.preteyeres.2016.12.004.Carreon T, van der Merwe E, Fellman RL, et al. Aqueous outflow - A
continuum from trabecular meshwork to episcleral veins[J]. Prog Retin
Eye Res, 2017, 57: 108-133. DOI: 10.1016/j.preteyeres.2016.12.004.
11、Kaur I, Kaur J, Sooraj K, et al. Comparative evaluation of the aqueous
humor proteome of primary angle closure and primary open angle
glaucomas and age-related cataract eyes[J]. Int Ophthalmol, 2019,
39(1): 69-104. DOI: 10.1007/s10792-017-0791-0.Kaur I, Kaur J, Sooraj K, et al. Comparative evaluation of the aqueous
humor proteome of primary angle closure and primary open angle
glaucomas and age-related cataract eyes[J]. Int Ophthalmol, 2019,
39(1): 69-104. DOI: 10.1007/s10792-017-0791-0.
12、Kaur I, Kaur J, Sooraj K, et al. Comparative evaluation of the aqueous
humor proteome of primary angle closure and primary open angle
glaucomas and age-related cataract eyes[J]. Int Ophthalmol, 2019,
39(1): 69-104. DOI: 10.1007/s10792-017-0791-0.Kaur I, Kaur J, Sooraj K, et al. Comparative evaluation of the aqueous
humor proteome of primary angle closure and primary open angle
glaucomas and age-related cataract eyes[J]. Int Ophthalmol, 2019,
39(1): 69-104. DOI: 10.1007/s10792-017-0791-0.
13、Charo IF, Ransohoff RM. The many roles of chemokines and
chemokine receptors in inflammation[J]. N Engl J Med, 2006, 354(6):
610-621. DOI: 10.1056/NEJMra052723.Charo IF, Ransohoff RM. The many roles of chemokines and
chemokine receptors in inflammation[J]. N Engl J Med, 2006, 354(6):
610-621. DOI: 10.1056/NEJMra052723.
14、Attur M, Krasnokutsky S, Statnikov A, et al. Low-grade inflammation
in symptomatic knee osteoarthritis: prognostic value of inflammatory
plasma lipids and peripheral blood leukocyte biomarkers[J]. Arthritis
Rheumatol, 2015, 67(11): 2905-2915. DOI: 10.1002/art.39279.Attur M, Krasnokutsky S, Statnikov A, et al. Low-grade inflammation
in symptomatic knee osteoarthritis: prognostic value of inflammatory
plasma lipids and peripheral blood leukocyte biomarkers[J]. Arthritis
Rheumatol, 2015, 67(11): 2905-2915. DOI: 10.1002/art.39279.
15、Scanzello CR, Loeser RF. Editorial: inflammatory activity in
symptomatic knee osteoarthritis: not all inflammation is local[J].
Arthritis Rheumatol, 2015, 67(11): 2797-2800. DOI: 10.1002/
art.39304.Scanzello CR, Loeser RF. Editorial: inflammatory activity in
symptomatic knee osteoarthritis: not all inflammation is local[J].
Arthritis Rheumatol, 2015, 67(11): 2797-2800. DOI: 10.1002/
art.39304.
16、Sekula P, Fabiola Greco M, Pattaro C, et al. Mendelian randomization
as an approach to assess causality using observational data[J]. J Am Soc
Nephrol, 2016, 27(11): 3253-3265. DOI: 10.1681/ASN.2016010098.Sekula P, Fabiola Greco M, Pattaro C, et al. Mendelian randomization
as an approach to assess causality using observational data[J]. J Am Soc
Nephrol, 2016, 27(11): 3253-3265. DOI: 10.1681/ASN.2016010098.
17、Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a
review[J]. Res Synth Methods, 2019, 10(4): 486-496. DOI: 10.1002/
jrsm.1346.Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a
review[J]. Res Synth Methods, 2019, 10(4): 486-496. DOI: 10.1002/
jrsm.1346.
18、Burgess S, Thompson SG. Interpreting findings from Mendelian
randomization using the MR-Egger method[J]. Eur J Epidemiol, 2017,
32(5): 377-389. DOI: 10.1007/s10654-017-0255-x.Burgess S, Thompson SG. Interpreting findings from Mendelian
randomization using the MR-Egger method[J]. Eur J Epidemiol, 2017,
32(5): 377-389. DOI: 10.1007/s10654-017-0255-x.
19、Levin MG, Judy R, Gill D, et al. Genetics of height and risk of atrial
fibrillation: a Mendelian randomization study[J]. PLoS Med, 2020,
17(10): e1003288. DOI: 10.1371/journal.pmed.1003288.Levin MG, Judy R, Gill D, et al. Genetics of height and risk of atrial
fibrillation: a Mendelian randomization study[J]. PLoS Med, 2020,
17(10): e1003288. DOI: 10.1371/journal.pmed.1003288.
20、Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci
affecting mean telomere length and their association with disease[J].
Nat Genet, 2013, 45(4): 422-427, 427e1-427e2. DOI: 10.1038/
ng.2528.Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci
affecting mean telomere length and their association with disease[J].
Nat Genet, 2013, 45(4): 422-427, 427e1-427e2. DOI: 10.1038/
ng.2528.
21、Han Y, Zhang Y, Zeng X. Assessment of causal associations between
uric acid and 25-hydroxyvitamin D levels[J]. Front Endocrinol, 2022,13: 1024675. DOI: 10.3389/fendo.2022.1024675.Han Y, Zhang Y, Zeng X. Assessment of causal associations between
uric acid and 25-hydroxyvitamin D levels[J]. Front Endocrinol, 2022,13: 1024675. DOI: 10.3389/fendo.2022.1024675.
22、Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence
of rheumatoid arthritis, based on the 1987 American College of
Rheumatology criteria: a systematic review[J]. Semin Arthritis Rheum,
2006, 36(3): 182-188. DOI: 10.1016/j.semarthrit.2006.08.006.Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence
of rheumatoid arthritis, based on the 1987 American College of
Rheumatology criteria: a systematic review[J]. Semin Arthritis Rheum,
2006, 36(3): 182-188. DOI: 10.1016/j.semarthrit.2006.08.006.
23、Markovitz E, Perry ZH, Tsumi E, et al. Ocular involvement and its'
manifestations in rheumatoid arthritis patients[J]. Harefuah, 2011,
150(9): 713-718, 751.Markovitz E, Perry ZH, Tsumi E, et al. Ocular involvement and its'
manifestations in rheumatoid arthritis patients[J]. Harefuah, 2011,
150(9): 713-718, 751.
24、Bjordal%20O%2C%20Norheim%20KB%2C%20R%C3%B8dahl%20E%2C%20et%20al.%20Primary%20Sj%C3%B6gren's%20syndrome%0Aand%20the%20eye%5BJ%5D.%20Surv%20Ophthalmol%2C%202020%2C%2065(2)%3A%20119-132.%20DOI%3A%0A10.1016%2Fj.survophthal.2019.10.004.Bjordal%20O%2C%20Norheim%20KB%2C%20R%C3%B8dahl%20E%2C%20et%20al.%20Primary%20Sj%C3%B6gren's%20syndrome%0Aand%20the%20eye%5BJ%5D.%20Surv%20Ophthalmol%2C%202020%2C%2065(2)%3A%20119-132.%20DOI%3A%0A10.1016%2Fj.survophthal.2019.10.004.
25、Bjordal%20O%2C%20Norheim%20KB%2C%20R%C3%B8dahl%20E%2C%20et%20al.%20Primary%20Sj%C3%B6gren's%20syndrome%0Aand%20the%20eye%5BJ%5D.%20Surv%20Ophthalmol%2C%202020%2C%2065(2)%3A%20119-132.%20DOI%3A%0A10.1016%2Fj.survophthal.2019.10.004.Bjordal%20O%2C%20Norheim%20KB%2C%20R%C3%B8dahl%20E%2C%20et%20al.%20Primary%20Sj%C3%B6gren's%20syndrome%0Aand%20the%20eye%5BJ%5D.%20Surv%20Ophthalmol%2C%202020%2C%2065(2)%3A%20119-132.%20DOI%3A%0A10.1016%2Fj.survophthal.2019.10.004.
26、D%C3%B6nerta%C5%9F%20HM%2C%20Fabian%20DK%2C%20Valenzuela%20MF%2C%20et%20al.%20Common%20genetic%0Aassociations%20between%20age-related%20diseases%5BJ%5D.%20Nat%20Aging%2C%202021%2C%201(4)%3A%0A400-412.%20DOI%3A%2010.1038%2Fs43587-021-00051-5.D%C3%B6nerta%C5%9F%20HM%2C%20Fabian%20DK%2C%20Valenzuela%20MF%2C%20et%20al.%20Common%20genetic%0Aassociations%20between%20age-related%20diseases%5BJ%5D.%20Nat%20Aging%2C%202021%2C%201(4)%3A%0A400-412.%20DOI%3A%2010.1038%2Fs43587-021-00051-5.
27、Cargnello M, Roux PP. Activation and function of the MAPKs and
their substrates, the MAPK-activated protein kinases[J]. Microbiol Mol
Biol Rev, 2011, 75(1): 50-83. DOI: 10.1128/MMBR.00031-10.Cargnello M, Roux PP. Activation and function of the MAPKs and
their substrates, the MAPK-activated protein kinases[J]. Microbiol Mol
Biol Rev, 2011, 75(1): 50-83. DOI: 10.1128/MMBR.00031-10.
28、Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in
human diseases[J]. Biochim Biophys Acta, 2010, 1802(4): 396-405.
DOI: 10.1016/j.bbadis.2009.12.009.Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in
human diseases[J]. Biochim Biophys Acta, 2010, 1802(4): 396-405.
DOI: 10.1016/j.bbadis.2009.12.009.
29、Ye M, Luo X, Li L, et al. Grifolin, a potential antitumor natural product
from the mushroom Albatrellus confluens, induces cell-cycle arrest in
G1 phase via the ERK1/2 pathway[J]. Cancer Lett, 2007, 258(2): 199-207. DOI: 10.1016/j.canlet.2007.09.001.Ye M, Luo X, Li L, et al. Grifolin, a potential antitumor natural product
from the mushroom Albatrellus confluens, induces cell-cycle arrest in
G1 phase via the ERK1/2 pathway[J]. Cancer Lett, 2007, 258(2): 199-207. DOI: 10.1016/j.canlet.2007.09.001.
30、Han H, Wecker T, Grehn F, et al. Elasticity-dependent modulation
of TGF-β responses in human trabecular meshwork cells[J]. Invest
Ophthalmol Vis Sci, 2011, 52(6): 2889-2896. DOI: 10.1167/iovs.10-
6640.Han H, Wecker T, Grehn F, et al. Elasticity-dependent modulation
of TGF-β responses in human trabecular meshwork cells[J]. Invest
Ophthalmol Vis Sci, 2011, 52(6): 2889-2896. DOI: 10.1167/iovs.10-
6640.
31、Liton PB, Li G, Luna C, et al. Cross-talk between TGF-beta1 and IL-6
in human trabecular meshwork cells[J]. Mol Vis, 2009, 15: 326-334.Liton PB, Li G, Luna C, et al. Cross-talk between TGF-beta1 and IL-6
in human trabecular meshwork cells[J]. Mol Vis, 2009, 15: 326-334.
32、Ding SL, Pang ZY, Chen XM, et al. Urolithin a attenuates IL-1β-
induced inflammatory responses and cartilage degradation via
inhibiting the MAPK/NF-κB signaling pathways in rat articular
chondrocytes[J]. J Inflamm, 2020, 17: 13. DOI: 10.1186/s12950-020-
00242-8.Ding SL, Pang ZY, Chen XM, et al. Urolithin a attenuates IL-1β-
induced inflammatory responses and cartilage degradation via
inhibiting the MAPK/NF-κB signaling pathways in rat articular
chondrocytes[J]. J Inflamm, 2020, 17: 13. DOI: 10.1186/s12950-020-
00242-8.
33、Zhang XF, Ma JX, Wang YL, et al. Calcyclin (S100A6) attenuates
inflammatory response and mediates apoptosis of chondrocytes in
osteoarthritis via the PI3K/AKT pathway[J]. Orthop Surg, 2021,
13(3): 1094-1101. DOI: 10.1111/os.12990.Zhang XF, Ma JX, Wang YL, et al. Calcyclin (S100A6) attenuates
inflammatory response and mediates apoptosis of chondrocytes in
osteoarthritis via the PI3K/AKT pathway[J]. Orthop Surg, 2021,
13(3): 1094-1101. DOI: 10.1111/os.12990.
34、Li RX, Wang Q, Shen ZW, et al. MTIM affects retinal ganglion cells
through PI3K/AKT signaling pathway[J]. Eur Rev Med Pharmacol Sci,
2020, 24(10): 5209-5216. DOI: 10.26355/eurrev_202005_21302.Li RX, Wang Q, Shen ZW, et al. MTIM affects retinal ganglion cells
through PI3K/AKT signaling pathway[J]. Eur Rev Med Pharmacol Sci,
2020, 24(10): 5209-5216. DOI: 10.26355/eurrev_202005_21302.
35、Blindness and vision impairment[EB/OL]. [2022-10-03].https://
www.who.int/news-room/fact-sheets/detail/blindness-and-visual-
impairment.Blindness and vision impairment[EB/OL]. [2022-10-03].https://
www.who.int/news-room/fact-sheets/detail/blindness-and-visual-
impairment.